Research Topics
| Charalambos AndreadisSummaryAffiliation: University of Pennsylvania Country: USA Publications
| Collaborators
|
Detail Information
Publications
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphomaC Andreadis
Bone Marrow and Stem Cell Transplantation Program and Lymphoma Program, The Abramson Cancer Center, University of Pennsylvania, 16 Penn Tower, 3400 Spruce Street, Philadelphia, 19104, USA
Bone Marrow Transplant 36:955-61. 2005..ASCT is thus a safe therapeutic approach in FL, resulting in long-term EFS and OS for some patients, even with transformed disease...
Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphomaCharalambos Andreadis
Abramson Cancer Center, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
Blood 109:3409-16. 2007....
Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and managementAnthony R Mato
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Cancer Biol Ther 6:1867-70. 2007..We present the case of an 82 yr old male with newly diagnosed PCL and two years of subsequent follow up. This report highlights the utility of a multimodality imaging approach in the diagnosis and management of PCL...
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell supportDan T Vogl
Bone Marrow and Stem Cell Transplant Program, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Am J Hematol 82:1071-5. 2007..Future trials comparing induction therapies should examine progression-free and overall survival after transplant to confirm this benefit...
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai
Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Clin Cancer Res 14:5619-25. 2008..We therefore conducted a phase I dose escalation study to assess the maximum tolerated dose, toxicities, and activity of bexarotene in patients with non-M3 acute myeloid leukemia (AML)...
Primary lymphomas of the cervix and uterus: the University of Pennsylvania's experience and a review of the literatureNoelle V Frey
Abramson Cancer Center of the Hospital of the University of Pennsylvania, 3400 Spruce, Philadelphia, PA 19104, USA
Leuk Lymphoma 47:1894-901. 2006..In general, patients with limited stage disease should be treated with localized and systemic therapy to optimize chances of cure...
Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejectionVivek N Ahya
Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
J Heart Lung Transplant 26:839-44. 2007..We investigated the hypothesis that detection of latent Epstein-Barr virus (EBV) in peripheral blood may be a functional marker for the net effects of administered immunosuppression...
Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?David Fuster
Nuclear Medicine Division Radiology Department, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Nucl Med Commun 27:11-5. 2006..To assess the usefulness of [18F]fluorodeoxyglucose positron emission tomography in the detection of bone marrow involvement in malignant lymphoma, and its impact in clinical management...
Regression of pulmonary MALT lymphoma after treatment with rituximabElise A Chong
Hematology-Oncology Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
Leuk Lymphoma 46:1383-6. 2005..This case report demonstrates the potential efficacy of rituximab as a single therapeutic agent in patients with pulmonary MALT lymphoma...
NSC 290205-based therapy in murine pancreatic adenocarcinoma PAN02 in combination with adriamycin (ADR)Athanasios Papageorgiou
Department of Experimental Chemotherapy, Symeonidion Research Center, Thessaloniki, Greece
Anticancer Res 26:243-7. 2006..In this study, the antitumor activity of A in combination with ADR (AHOP) was investigated in comparison with the standard CHOP regimen...
Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancerConstantine Gennatas
Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
Anticancer Res 26:549-52. 2006..To evaluate the activity and toxicity of gemcitabine and vinorelbine in patients with metastatic breast cancer (MBC), previously treated with anthracyclines alone or with taxanes...
Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreasConstantine Gennatas
Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
In Vivo 20:301-5. 2006..The aim of the study was to evaluate the safety and efficacy of the combination of gemcitabine and 5-FU in patients with advanced adenocarcinoma of the pancreas...
